Ibrutinib for use as a medicament for treating bronchiolitis obliterans syndrome

摘要

Described herein are methods for treating and preventing alloantibody driven chronic graft versus host disease (cGVHD). The methods include administering to an individual in need thereof ibrutinib for treating and preventing alloantibody driven graft versus host disease.